Ebook Immunohematology and transfusion medicine - A case study approach: Part 2

100 73 0
Ebook Immunohematology and transfusion medicine - A case study approach: Part 2

Đang tải... (xem toàn văn)

Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống

Thông tin tài liệu

(BQ) Part 2 book Immunohematology and transfusion medicine - A case study approach presents the following contents: Playing with enzymes, differential alloadsorption, the case of low platelets, cruising for a bruising, do the math,...

Chapter 14 Playing with Enzymes Clinical History A 70-year-old female of African American decent, with history of hypertension, type diabetes mellitus, anemia, and congestive heart failure, is admitted to the hospital because of symptomatic anemia (hemoglobin, Hgb level 7.2  g/dL) The patient has a history of red blood cell (RBC) transfusions and is known to have alloantibodies (anti-C, -K, and -Fya) The patient was last transfused two units of RBCs weeks ago Two RBC units are now requested, and a type and crossmatch sample (ethylenediaminetetraacetic acid, EDTA anticoagulant) is submitted to the blood bank ABO/Rh/Antibody Screen ABO/Rh (gel method) Patient RBCs (forward typing) Anti-A Anti-B Anti-D 0 4+ Antibody screen (gel method) SC1 2+ SC2 2+ Reaction scale = 0 (no reaction) to 4+ (strong reaction) RBC red blood cell Patient plasma (reverse typing) A1 cells B cells 4+ 4+ &URVVPDWFKHG5%&¶V *URXS2&.)\D DQWLJHQ1HJDWLYH $+* && 'RQRU8QLW  17 'RQRU8QLW  17 © Springer International Publishing Switzerland 2016 M T Friedman et al., Immunohematology and Transfusion Medicine, DOI 10.1007/978-3-319-22342-1_14 67 5 5 5 5 5 5 5 U 5 U UU UU 5 U UU 5 U                     '           &           (           F           H 5KKU           I           & Z                               N 3RO\VSHFLILF: 5HDFWLRQVFDOH  QRUHDFWLRQ WR VWURQJUHDFWLRQ  3DWLHQW &HOO 5KKU &HOO  *HODQG(Q]\PH3DQHO 6HOHFWHG&HOOV            S D E           S HOO           -V D           )\ D E           )\ 'XII\ ,J*: '$73URILOH           -V E           -N D E           -N LGG           /H D           /H /HZLV E                               016           V   6  :           /X E &G        :   6    /X D /XWKHUDQ   3               :       *HO 17           )LFLQ 7HVW5HVXOWV &HOO  68 14  Playing with Enzymes UU UU UU 5 5                 &           '            (            F            H 5KKU            I            &Z                                  N            SE            -VD            -VE            )\D            )\E 'XII\            -ND            -NE LGG            /HD            /HE /HZLV $QWLJHQ3KHQRW\SH5HVXOWV 3ULRU+LVWRU\            SD HOO                                  016 V            '& ( FH. )\D )\E -ND-NE6 V013/HD /HE 5HDFWLRQVFDOH  QRUHDFWLRQ WR VWURQJUHDFWLRQ  /DVW:DVK6& /DVW:DVK6& UU  5 U  U U 5 5  UU 5 5   5:5   5KKU &HOO  $FLG(OXDWH3DQHO   6    :        :   6    /XD            /XE /XWKHUDQ   3            &HOO     17 17  17 17 17  17 17 17 17             && ,$77XEH $+* 7HVW5HVXOWV 17 17   17    17     )LFLQ ABO/Rh/Antibody Screen 69 WR VWURQJUHDFWLRQ    17       17 17 17 17 && 7HVW5HVXOWV  5 5    ( LGG /DVW:DVK6& 5 5   & 'XII\ &G  5:5  ' HOO '$73URILOH ,J* /DVW:DVK6& 5KKU &HOO  5KKU $FLG(OXDWH3DQHO 3RO\VSHFLILF ABO/Rh/Antibody Screen  111 112 22  The Case of Low Platelets Questions  What antibodies did you identify in the patient’s sample? What are the possible sources of the antibodies, and how does the patient’s history and laboratory values lead you to the most likely source? In consideration of the platelet count, is platelet transfusion indicated for this patient? Why or why not? Inlight of the patient’s Rh(D) type and the antibody present in the panel, would you transfuse this patient with Rh-positive or Rh-negative blood? Answers What antibodies did you identify in the patient’s sample? Anti-D is apparently present However, given that the patient is Rh positive, it is not certain from the panel whether the antibody is an auto- or an alloantibody The latter would occur in the case of a partial-D type Adsorption with D-positive and D-negative cells could possibly differentiate the two as an autoanti-D (which has broad reactivity) and could be removed by adsorption with both D-positive and D-negative cells while an alloanti-D would be removed only by adsorption with D-positive cells Finally, an autoanti-LW (LW is a blood group antigen that is closely associated with the Rh(D) antigen) should also be considered and may be distinguished through testing with dithiothreitol (DTT)-treated cells; DTT destroys LW antigen but not Rh(D) antigen What are the possible sources of the antibodies, and how does the patient’s history and laboratory values lead you to the most likely source? In light of the above discussion, alloanti-D may have been acquired through prior transfusion or pregnancy exposure to the Rh(D) antigen if the patient is a partial-D type However, in this case, because of the patient’s thrombocytopenia, the patient was suspected to have idiopathic thrombocytopenic purpura (ITP) and history was promptly obtained that in fact the patient had received IV Rh immunoglobulin (RhIg) several weeks ago for treatment of the ITP Thus, based upon this history, it is apparent that the anti-D was passively acquired, and further work up to differentiate an autoanti-D or an autoanti-LW was unnecessary IV RhIg is specifically indicated for treatment of ITP in patients who are Rh positive, who have a functioning spleen, and who are not significantly anemic (since the treatment causes further anemia through IgG coating of Rh-positive RBCs and removal via the spleen, essentially an iatrogenic hemolytic anemia) For more information on IV RhIg in the treatment of thrombocytopenia, refer to Chap #6, question Is platelet transfusion indicated for this patient? Why or why not? Since the patient has ITP, platelet transfusion is generally contraindicated unless there is life-threatening bleeding Recommended Reading 113 In light of the patient’s Rh(D) type and the antibody present in the panel, would you transfuse this patient with Rh-positive or Rh-negative blood? Since the goal of RBC transfusion is to treat the patient’s anemia (i.e., increase the Hgb level), Rh-negative blood might be paradoxically given to this Rh-positive patient in the presence of the passively acquired anti-D (which could shorten the survival of transfused Rh-positive blood) Recommended Reading Klein HG, Anstee DJ The transfusion of platelets, leucocytes, haematopoietic progenitor cells and plasma components In: Klein HG, Anstee DJ, editors Mollison’s blood transfusion in clinical medicine 12th ed West Sussex: Wiley; 2014 p. 625 Chapter 23 The Perils of Transfusing the Sickle Cell Patient Clinical History A 44-year-old female with sickle cell disease presents to the emergency department with acute pain crisis (pain in shoulders and upper back) The patient’s hemoglobin (Hgb) level is 7.2 g/dL, which is around her usual baseline Hgb The patient received RBC units in the outpatient department of another hospital days prior to admission (her Hgb level was 7.6 g/dL prior to transfusion at that time), and as per that hospital’s blood bank, the patient has an antibody history of warm autoantibody, anti-Fya, and anti-Jkb Overnight in the emergency department, the patient’s blood pressure dropped to 90/56 mmHg, and the Hgb level dropped to 5.4 g/dL with total bilirubin (T-Bili) level 15.3 mg/dL and the lactate dehydrogenase (LDH) level 10,000 U/L The patient is admitted to the the medical intensive care unit (MICU), and a type and screen sample (ethylenediaminetetraacetic acid, EDTA anticoagulant) is submitted to the blood bank along with a request for two units of RBCs ABO/Rh/Antibody Screen ABO/Rh (gel method) Patient RBCs (forward typing) Patient plasma (reverse typing) Anti-A Anti-B Anti-D A1 cells B cells 0 4+ 4+ 4+ Antibody screen (Gel method) SC1 1+ SC2 1+ Reaction scale = 0 (no reaction) to 4+ (strong reaction) RBC red blood cell, SC screen cell © Springer International Publishing Switzerland 2016 M T Friedman et al., Immunohematology and Transfusion Medicine, DOI 10.1007/978-3-319-22342-1_23 115 5:5 5  5  5 U U U UU UU UU UU UU 5 5                       '            &            (            F            H 5KKU            I            &Z                                  N 5HDFWLRQVFDOH  QRUHDFWLRQ WR VWURQJUHDFWLRQ  3DWLHQW &HOO 5KKU &HOO  *HO3DQHO            SD            SE HOO            -VD            -VE            )\D            )\E 'XII\            -ND            -NE LGG            /HD            /HE /HZLV                                  016            V    : 6    :           6    /XD            /XE /XWKHUDQ   3   :  :  :   :  : :     :  : :   *HO &HOO  7HVW 5HVXOWV 116 23  The Perils of Transfusing the Sickle Cell Patient 5U U U UU UU UU UU UU 55                                                  F            H            I            &Z                                  N            SD            SE                   -VE     -VD            )\D            )\E            -ND            -NE            /HD            /HE /HZLV                                  016            V  :       6  6  :      6  /XD            /XE /XWKHUDQ   31            &HOO  : : : : : W+ : : : : : $+* 5HDFWLRQVFDOH  QRUHDFWLRQ WR VWURQJUHDFWLRQ   17 17 17 17 17 17 17 17 17 17 17 CC 7HVW5HVXOWV ,$77XEH  55    ( LGG /DVW:DVK6& 55   & 'XII\ &G  5:5  ' HOO ,J*: /DVW:DVK6& 5KKU &HOO  5KKU $FLG(OXDWH3DQHO 3RO\VSHFLILF: '$73URILOH ABO/Rh/Antibody Screen  117 5:5 5 5 5 5 5 U U U UU UU UU UU UU 5 5                       '            &            (            F            H            I            &Z                                  N            SD 5HDFWLRQVFDOH  QRUHDFWLRQ WR VWURQJUHDFWLRQ  3DWLHQW &HOO 5KKU &HOO  5KKU 7XEHDQG(Q]\PH3DQHO            SE HOO            -VD            -VE            )\D            )\E 'XII\            -ND            -NE LGG            /HD            /HE /HZLV                                  016            V    : 6 6   :             /XD            /XE /XWKHUDQ   3            &HOO    :    :  :      17    17  17    && ,$77XEH $+* 7HVW5HVXOWV 17 17  17 17 17  17 : 17 17 17 )LFLQ 118 23  The Perils of Transfusing the Sickle Cell Patient 5 U 5 U         '      &      (      F      H      I      &Z                N      SD 5HDFWLRQVFDOH  QRUHDFWLRQ ... International Publishing Switzerland 20 16 M T Friedman et al., Immunohematology and Transfusion Medicine, DOI 10.1007/97 8-3 -3 1 9 -2 234 2- 1 _15 73 74 15  The Platelet Transfusion shaking chills, and. .. West KA, et  al Low incidence of anti-D alloimmunization following D+ platelet transfusion The Anti-D alloimmunization after D-incompatible platelet transfusions (ADAPT) study Br J Haematol 20 15;168(4):598–603... to antigen-negative RBCs for previously identified alloantibodies (anti-C, -K, and -Fya), the patient also needs RBCs that are negative for S antigen and Fy3 antigen (RBCs lacking Fy3 antigen also

Ngày đăng: 20/01/2020, 10:11

Mục lục

  • Preface

  • Contents

  • List of Abbreviations

  • Authors’ Note

  • Chapter-1

    • Basic Single Antibody Identification: How Hard Can It Be?

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Questions

      • Answers

      • Reference

      • Recommended Reading

  • Chapter-2

    • Rhesus Pieces

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Questions

      • Answers

      • References

  • Chapter-3

    • Cold Case

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Questions

      • Answers

      • Recommended Reading

  • Chapter-4

    • Child’s Play

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Questions

      • Answers

      • Recommended Reading

  • Chapter-5

    • I Can “See” Clearly Now

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Questions

      • Answers

      • References

      • Recommended Reading

  • Chapter-6

    • You Really “Oughta” Get This

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Questions

      • Answers

      • Recommended Reading

  • Chapter-7

    • What the Kell

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Additional Study: 4°C Incubation (Cold Panel)

      • Questions

      • Answers

      • References

      • Recommended Reading

  • Chapter-8

    • EeeeeK!!!

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Questions

      • Answers

      • References

      • Recommended Reading

  • Chapter-9

    • Are You Kidding?

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Questions

      • Answers

      • Recommended Reading

  • Chapter-10

    • G-Force

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Neonatal Results

      • Test Results

      • Questions

      • Answers

      • Recommended Reading

  • Chapter-11

    • Hide and Seek

      • Clinical History

      • ABO/Rh/Antibody Screen

      • PEG Results (Crossmatch and Antibody Screen)

      • Questions

      • Answers

      • Recommended Reading

  • Chapter-12

    • The Transfusion Reaction

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Additional History

      • Test Results: Posttransfusion Sample

      • Posttransfusion Sample Antibody Screen and Crossmatch

      • Questions

      • Answers

      • References

      • Recommended Reading

  • Chapter-13

    • What’s This Junk?

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Antibody Titration

      • Answers

      • Reference

      • Recommended Reading

  • Chapter-14

    • Playing with Enzymes

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Questions

      • Answers

      • References

  • Chapter-15

    • The Platelet Transfusion

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Additional History

      • Test Results: Posttransfusion Sample

      • Questions

      • Answers

      • Recommended Reading

  • Chapter-16

    • Differential Alloadsorption

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Questions

      • Answers

      • Reference

      • Recommended Reading

  • Chapter-17

    • Hey, How Did That Antibody Get There?

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Questions

      • Answers

      • Reference

      • Recommended Reading

  • Chapter-18

    • I Can’t Stop the Hemolysis!

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Additional History

      • Questions

      • Answers

      • References

  • Chapter-19

    • Just Another Autoantibody

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Questions

      • Answers

      • Recommended Reading

  • Chapter-20

    • I Got You Baby

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Questions

      • Answers

      • References

  • Chapter-21

    • “You” Got that Right

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Questions

      • Answers

      • Recommended Reading

  • Chapter-22

    • The Case of Low Platelets

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Answers

      • Recommended Reading

  • Chapter-23

    • The Perils of Transfusing the Sickle Cell Patient

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Additional History

      • Questions

      • Answers

      • Recommended Reading

  • Chapter-24

    • To KB or Not to KB, That is the Question

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Questions

      • Answers

      • Recommended Reading

  • Chapter-25

    • It May Do Harm

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Questions

      • Answers

      • Reference

  • Chapter-26

    • Fuggedaboutit

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Additional History

      • Test Results: Posttransfusion Sample

      • Questions

      • Answers

      • Recommended Reading

  • Chapter-27

    • Bad Medicine

      • Clinical History

      • ABO/Rh/Antibody Screen

      • DAT Profile and Acid Eluate Panel

      • Questions

      • Answers

      • Reference

      • Recommended Reading

  • Chapter-28

    • In the Clouds

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Questions

      • Answers

      • References

  • Chapter-29

    • Emergency!

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Questions

      • Answers

      • Reference

  • Chapter-30

    • Time to Change the Plasma

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Questions

      • Answers

      • Recommended Reading

  • Chapter-31

    • Do the Math!

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Additional History

      • Questions

      • Answers

      • Reference

      • Recommended Reading

  • Chapter-32

    • Eight is Enough!

      • Clinical History

      • Questions

      • Answers

      • Reference

      • Recommended Reading

  • Chapter-33

    • Cruising for a Bruising

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Additional History

      • Answers

      • References

  • Chapter-34

    • Help, I Cannot Stop the Bleeding!

      • Clinical History

      • ABO/Rh/Antibody Screen

      • Questions

      • Answers

      • References

      • Recommended Reading

  • Chapter-35

    • Saving Blood

      • Clinical History

      • References

      • Recommended Reading

  • Index

Tài liệu cùng người dùng

  • Đang cập nhật ...

Tài liệu liên quan